Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15Yang Xu, Gianpietro Dotti, Ming Zhang et al.|Blood|2014Cited by 738
Clinical and immunological responses after CD30-specific chimeric antigen receptor–redirected lymphocytesCarlos A. Ramos, Barbara Savoldo|Journal of Clinical Investigation|2017Cited by 368
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletionLeila Amini, Mohamed Abou‐El‐Enein, Carlos A. Ramos et al.|Nature Reviews Clinical Oncology|2022Cited by 324
Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugsSoranobu Ninomiya, Carlos A. Ramos|Blood|2015Cited by 312
Clinical responses with T lymphocytes targeting malignancy-associated κ light chainsCarlos A. Ramos, Gianpietro Dotti|Journal of Clinical Investigation|2016Cited by 280